Cesia Marquez

Appearances

PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S.
Date
May 21, 2024
BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
Presenter
Naoto Fujiwara
Speakers
Camden Lopez
Tracey Marsh
Indu Raman
Cesia Marquez
Subhojit Paul
Sumit Mishra
Naoto Kubota
Courtney Katz
Hiroaki Kanzaki
Michael Gonzales
Lisa Quirk
Sneha Deodhar
Pratibha Selvakumar
Prithvi Raj
Neehar Parikh
University of Michigan
Lewis Roberts
Mayo Foundation for Medical Education and Research
Myron Schwartz
Mindie Nguyen
Alex Befeler
Stephanie Page-Lester
Jo Ann Rinaudo
Ziding Feng
Rajender Reddy
Saira Khaderi
Baylor College of Medicine
Sumeet K. Asrani
Baylor University Medical Center
Fasiha Kanwal
Michael E. DeBakey VAMC
Hashem El-Serag
Baylor College of Medicine
Jorge Marrero
Amit Singal
UT Southwestern Medical Center
Yujin Hoshida
University of Texas Southwestern Medical Center